Picture of Stereotaxis logo

STXS Stereotaxis Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Stereotaxis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments30.243.938.728.419.8
Net Total Accounts Receivable
Net Total Receivables5.333.525.415.093.82
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets38.852.751.443.233.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment4.542.438.379.218.29
Other Long Term Assets
Total Assets43.655.56153.441.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities12.213.613.314.313.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities15.115.221.621.520
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity28.540.239.431.921.9
Total Liabilities & Shareholders' Equity43.655.56153.441.9
Total Common Shares Outstanding
Total Preferred Shares Outstanding